RECURRENT
Clinical trials for RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECURRENT trials appear
Sign up with your email to follow new studies for RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine aims to boost immune attack on kidney tumors
Disease control Not yet recruitingThis early-stage trial tests whether a personalized vaccine, made from each patient's unique tumor mutations, can safely boost the effects of the immunotherapy drug pembrolizumab in people with advanced kidney cancer. The vaccine is designed to train the immune system to recogniz…
Matched conditions: RECURRENT
Phase: PHASE1 • Sponsor: Jian Lin • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Promising drug cocktail targets Hard-to-Treat cervical cancer
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—Utidelone and Toripalimab—in people with recurrent or metastatic cervical cancer that has stopped responding to standard treatments. All 32 participants will receive the same treatment, and doctors will monitor tumor shrinkage …
Matched conditions: RECURRENT
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Acupuncture vs. UTIs: new trial tests needle therapy to stop infections
Prevention Not yet recruitingThis study tests whether electroacupuncture can prevent recurrent lower urinary tract infections in women. Over 300 participants will receive either real or sham electroacupuncture for 6 months, tracking infection episodes and antibiotic use. The goal is to see if this needle-bas…
Matched conditions: RECURRENT
Phase: NA • Sponsor: Yanjun Zhang, Baoyan Liu • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC